Skip to content

Clinical trials

Immunoblastic Lymphadenopathy trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20052
20081
20141
20182
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
BeiGene1
Boston Medical Center1
Celgene1
Institut Paoli-Calmettes1
SecuraBio1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy12
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Large-Cell, Anaplastic8
Lymphoma, Follicular7
Lymphoma, T-Cell, Cutaneous7
Burkitt Lymphoma6
Hodgkin Disease6
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma6
Lymphoma, B-Cell, Marginal Zone6

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.